In the rapidly-changing environment of the pharmaceutical industry, the innovative stride of Pharma 4.0 heralds a new era of drug production. This pivotal shift to smart manufacturing aligns with the principles of Industry 4.0, embedding digitalization and cutting-edge technology to meet the
Introduction Retro Biosciences, a pioneering biotech company, has embarked on an ambitious journey to extend human lifespan by a decade through innovative approaches to combat cellular aging. Its strategic partnership with Multiply Labs, a firm celebrated for advanced automation and robotic
In the dynamic realm of biopharmaceutical investments, the diverging analyst ratings for Can-Fite BioPharma (NYSE: CANF) underscore the complex calculus of betting on drug development firms. The stock analysis firm StockNews.com has planted its flag with a "hold" rating, signaling a
In an era where technology touches almost every aspect of our lives, mental health care has also experienced a digital transformation. Recent research sheds light on patient perspectives toward digital mental health technologies (DMHT). These tools, which range from mood tracking apps to meditation
In an industry where time-to-market is critical, a strategic collaboration between AGC Biologics, a global leader in biopharmaceutical development, and BioConnection, an aseptic filling expert, may be the key to unlocking faster pathways from laboratory to patient. As biotechnology firms grapple
The biopharmaceutical industry is on the cusp of a manufacturing evolution, largely due to advancements in analytical technologies. A key player that has emerged in this transformative period is Raman spectroscopy. Renowned for its rapid, nondestructive analysis capabilities, Raman spectroscopy is
Novo Holdings, a prominent Danish investment firm with a focus on life sciences, has recently cemented its standing in the biopharma manufacturing industry through a strategic acquisition. Securing a majority stake in Single Use Support, Novo Holdings ventures further into an increasingly vital
The Summit on Men's Health: A Focus on Overactive Bladder and BPH Vibegron's emergence as a potential treatment for overactive bladder (OAB) offers new hope to men concurrently managing benign prostatic hyperplasia (BPH). Recent data from Sumitomo Pharma America, Inc. (SMPA) presented
The dawn of a food revolution is upon us, with synthetic biology at the helm, ready to address critical issues like resource scarcity and population growth. The anticipated SynBioBeta 2024's food and ag panel sessions are likely to showcase significant advances in synthetic biology, signaling
The advances of nanotechnology offer farmers more targeted and efficient pesticide usage, but the implications for ecosystems are worrisome. As nano-pesticides gain traction, they promise to decrease the quantity of chemicals sprayed on crops, aiming for precision and controlled release. Yet,
